Cord Patent Service
HealthBaby Biotech Hong Kong Co., Ltd.
Cord Patent Service
HealthBaby Biotech Hong Kong Co., Ltd.
Back to Hall of Fame
HealthBaby Biotech (Hong Kong) Co., Ltd. (HealthBaby) is a subsidiary of SGX mainboard listed company with solid foothold in Asia covering Singapore, Hong Kong, Macau, India, Indonesia, Philippines, Malaysia, Myanmar, Vietnam and Thailand. HealthBaby is also Hong Kong’s most accredited cord blood laboratory (including CAP, AABB and HOKLAS).
Its exclusive cord technology has attained a Hong Kong patent, and it is the only local cord blood bank with this achievement. The patented technology exclusively extracts the whole umbilical cord tissue with unique processing, storage and culture methodology, which can fully enhance the quantity and viability of tissue cells after thawing to help patients in need.
Experiments showed that the cord tissues processed by HealthBaby patented technology can successfully be cultured and differentiated into other tissue cells (e.g. adipocytes, chondrocytes and vascular endothelial cells) and the cell colony number derived was over 20-fold of that derived from the non-minced ones.
At present, HealthBaby has obtained more than 90% market share in Hong Kong. The Group is recommended by most O&G doctors and also entrusted by most parents for 10 consecutive years in Hong Kong.
Highlights
HealthBaby’s patented technology exclusively extracts the whole umbilical cord tissue with unique processing, storage and culture methodology, which can fully enhance the quantity and viability of tissue cells after thawing.
View Website
Back to Hall of Fame
HealthBaby Biotech (Hong Kong) Co., Ltd. (HealthBaby) is a subsidiary of SGX mainboard listed company with solid foothold in Asia covering Singapore, Hong Kong, Macau, India, Indonesia, Philippines, Malaysia, Myanmar, Vietnam and Thailand. HealthBaby is also Hong Kong’s most accredited cord blood laboratory (including CAP, AABB and HOKLAS).
Its exclusive cord technology has attained a Hong Kong patent, and it is the only local cord blood bank with this achievement. The patented technology exclusively extracts the whole umbilical cord tissue with unique processing, storage and culture methodology, which can fully enhance the quantity and viability of tissue cells after thawing to help patients in need.
Experiments showed that the cord tissues processed by HealthBaby patented technology can successfully be cultured and differentiated into other tissue cells (e.g. adipocytes, chondrocytes and vascular endothelial cells) and the cell colony number derived was over 20-fold of that derived from the non-minced ones.
At present, HealthBaby has obtained more than 90% market share in Hong Kong. The Group is recommended by most O&G doctors and also entrusted by most parents for 10 consecutive years in Hong Kong.